💨 Abstract
TG Therapeutics Inc. (TGTX) reported a second-quarter profit of $28.2 million, or 17 cents per share, falling short of Wall Street's expectations of 32 cents per share. Despite missing earnings projections, the company's revenue of $141.1 million exceeded forecasts of $136 million.
Courtesy: WTOP Staff
Suggested
I Got Scammed: 6 Takeaways From How I Survived and Resolved Identity Theft -
Photos show Palestinians pursuing food aid after the latest air drops in Gaza -
Rescuers call off search for 11 people presumed dead in Pakistan floods -
Today in Sports - Warren Moon becomes the first black QB to be inducted into the NFL Hall of Fame -
Wild Card Glance -
Baseball Glance -
Israel euthanizes crocodiles after repeated escapes and inhumane treatment -
Flames and smoke force passengers to flee New York City area train -
Lula da Silva pide que Brasil sea tratado “como igual” en diálogo con EE.UU.: “No somos una república insignificante” -
Which chef took home the top prize at this year’s RAMMYS? -